Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
In the human, the AIRE (autoimmune regulator) gene is located on chromosome 21q22. 3, which consists of 14 exons, spanning 11. 9 kb of genomic DNA, encoding a protein of 545 amino acids with a molecular weight of about 57.5 kD. The AIRE protein is mainly localized in the nucleus and distributed in the nucleosomes near the nuclear speckle, suggesting that AIRE is involved in gene transcriptional regulation.
AIREp shares three domains with the Sp100 family, which are involved in the interaction of DNA-binding proteins and the regulation of transcription. The first is a homogeneously stained region (HSR domain) located between amino acids 1 and 106, which is expressed in all members of the Sp100 family and is thought to play a role in a variety of cellular processes, including growth control, apoptosis, and senescence. The second is the SAND domain located at amino acids 189-280. This domain is involved in chromatin remodeling activity. The Sp100 SAND domain contains a conserved KDWK sequence with a unique α/β folding structure that is predicted to play an important role in DNA binding. The third is two plant homology domains (PHD) located at amino acids 299-340 and amino acids 434-474, respectively. Their zinc finger domain may be a DNA-binding domain, and this structural mutation will cause a severe decline in AIRE transcriptional activation.
Figure 1. AIRE protein domains, key interacting partners, and mechanism of TRA gene expression. (Zumer, et al. 2016)
The molecular mechanism regulating the expression of the AIRE gene in vivo remains unclear. Current studies using luciferase reporter gene detection have identified a reasonable minimum promoter region for the AIRE gene. This region contains the binding sequences including the SP1, AP-1, NF-Y and ETS transcription factor families. In fact, luciferase reporter assays have shown that the AIRE gene promoter regulates the AIRE gene promoter. However, there have been no in vivo genetic studies to demonstrate whether these sequence-specific transcription factors play an important role in the regulation of AIRE expression.
Studies have shown that the promoter region of AIRE contains a high proportion of CpG sites that are methylated in cell lines with defective AIRE expression. Subsequent studies have shown that these CpG sites are hypomethylated in medullary thymic epithelial cells (mTEC) compared to thymocytes, suggesting that DNA demethylation may be a prerequisite of AIRE expression. However, hypomethylation was also observed in cEC and AIRE-deficient thymoma. Therefore, DNA hypomethylation appears to be necessary, but still not sufficient to induce AIRE expression. Overall, AIRE expression appears to be regulated by a combination of chromatin modifications and sequence-specific transcription factors. However, the exact mechanisms and regulatory molecules remain to be determined.
AIRE and Central Immune Tolerance
Negative selection of autoreactive thymocytes relies on mTEC-induced tissue-specific antigens (TSAs), and AIRE plays an important role in exposing these antigens. Its restricted expression in mTEC cells induces the expression of major histocompatibility complex (MHC)/human leukocyte antigen (HLA) molecules on the mTEC surface, thereby controlling the expression of thymus-specific tissue antigens. Mature thymocytes move and pass through the thymic medulla, and if their TCR recognizes the MHC-TSA complex with appropriate affinity, they will be overactivated and deleted. Through this process, the thymus reaches the role of clearing autoreactive T cells in the immune system.
Studies in transgenic mice have also shown that mice with insufficient AIRE develop clonal deletion disorders. Experiments to track autoantigen-specific T cells in mice have shown that autoreactive thymocytes can escape clone clearance in the usual sense in the case of AIRE knockout. It has been reported that mTECs can also mediate tolerance by directly presenting AIRE-regulated antigens to CD4 + and CD8 + T cells. Dendritic cells also have an effect on AIRE-driven antigen expression during central tolerance production. The recognition of MHC-TSA complexes can occur not only directly on MECs but also directly on DCs that have phagocytosed apoptotic MECs or MECs fragments.
The genes of TSAs in AIRE-controlled MECs are clustered in chromosomes. Some studies have found that AIRE acts as a transcription factor to directly promote TSA expression. In addition, AIRE can bind to DNA-PK or bind to hypomethylated histone 3 lysine 4 (H3K4) via its PHD domain, indicating AIRE plays a role in the repair in DNA double-strand breaks and altering chromatin in the TSA gene. They are critical for recruiting AIRE to the TSA gene locus and promoting TSA expression. In addition, it has been reported that AIRE can recruit P-TEFb to the TSA gene locus and promote the extension of captured TSA transcripts by releasing RNA polymerase II from the proximal promoter. Macedo et al. found that in addition to the expression of TSA, the expression of some microRNAs (miRNAs) was recently found to be AIRE-dependent, and genetic studies revealed that miRNA expression plays an important role in the function and maintenance of mTECs.
AIRE and Peripheral Tolerance
Lindex et al. detected AIRE in peripheral lymphoid organs, and RNA transcripts encoding AIRE have also been found in mouse and human monocytes as well as in dendritic cells (DCs), indicating either antigen presentation or it is said that AIRE has a possible extrathymic effect in regulating peripheral tolerance. The expression of AIRE in peripheral lymphoid organs can improve its function in the thymus. But the difference is that the role of AIRE in the periphery seems to be different from its function in the thymus. AIRE is found in the periphery to regulate the expression of a group of autoantigens that are not identical to those expressed in the thymus. It has also been found that AIRE has a regulatory effect on the maturation process of monocyte to dendritic cells (moDCs).
Gardner et al. found that AIRE transcripts, as well as nuclear AIRE proteins, are expressed in a unique tolerogenic stromal cell population called ETACs (extrathymosinal AIRE-expressing cells). These cells interact with and delete from naive autoreactive T cells, and some of the markers expressed are reminiscent of mTECs (eg, MHC class II, EpCAM), but these cells appear to lack expression of the canonical costimulatory molecules CD80 and CD86. Their recent studies have confirmed that ETACS is a group of bone marrow-derived antigen presenting cells (APCs) that are significantly different from dendritic cells (DCs) and stromal cell phenotypes. A comparison of wild-type and AIRE knockout mouse ETACs suggests that AIRE regulates a set of TSA, including several important autoantigens and genes important in antigen processing and presentation. This suggests that AIRE expression has a broad role in the expression of TSA in the periphery. By inactivating such cells, it was shown that AFE-mediated expression of PTA in ETACs may be an important mechanism for CD4 + T cell tolerance.
A comparison of wild-type and AIRE knockout mouse ETACs suggests that AIRE regulates a set of TSA, including several important autoantigens and genes important in antigen processing and presentation. This suggests that AIRE expression has a broad role in the expression of TSA in the periphery. By inactivating such cells, it was shown that AFE-mediated expression of PTA in ETACs may be an important mechanism for CD4 + T cell tolerance.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.